Bert van der Vegt

101 Article
41 Meeting Abstract
12 Review article
4 Comment/Letter to the editor
Meer

Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis
Zwager, M. C., Bense, R., Waaijer, S., Qiu, S. Q., Timmer-Bosscha, H., de Vries, E. G. E., Schröder, C. P. & van der Vegt, B., feb.-2023, In: Breast Cancer Research and Treatment. 198, 1, blz. 11-22 12 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

15 Downloads (Pure)
Association of Initial and Longitudinal Changes in C-reactive Protein With the Risk of Cardiovascular Disease, Cancer, and Mortality
Suthahar, N., Wang, D., Aboumsallem, J. P., Shi, C., de Wit, S., Liu, E. E., Lau, E. S., Bakker, S. J. L., Gansevoort, R. T., van der Vegt, B., Jovani, M., Kreger, B. E., Lee Splansky, G., Benjamin, E. J., Vasan, R. S., Larson, M. G., Levy, D., Ho, J. E. & de Boer, R. A., apr.-2023, In: Mayo clinic proceedings. 98, 4, blz. 549-558 10 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

2 Citaten (Scopus)

6 Downloads (Pure)
Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer
de Heer, E. C., Zois, C. E., Bridges, E., van der Vegt, B., Sheldon, H., Veldman, W. A., Zwager, M. C., van der Sluis, T., Haider, S., Morita, T., Baba, O., Schröder, C. P., de Jong, S., Harris, A. L. & Jalving, M., 28-aug.-2023, In: Journal of experimental & clinical cancer research. 42, 1 blz., 220.
Onderzoeksoutput

Open Access
Bestand

1 Downloads (Pure)
Digital image analysis of intraepithelial B-lymphocytes to assess lymphoepithelial lesions in salivary glands of Sjogren's syndrome patients
van Ginkel, M. S., van der Sluis, T., Bulthuis, M. L. C., Buikema, H. J., Haacke, E. A., Arends, S., Harder, S., Spijkervet, F. K. L., Bootsma, H., Vissink, A., Kroese, F. G. M. & van der Vegt, B., jan.-2023, In: Rheumatology. 62, 1, blz. 428–438 11 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

2 Citaten (Scopus)

29 Downloads (Pure)
EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial
de Wit, J. G., Vonk, J., Voskuil, F. J., de Visscher, S. A. H. J., Schepman, K-P., Hooghiemstra, W. T. R., Linssen, M. D., Elias, S. G., Halmos, G. B., Plaat, B. E. C., Doff, J. J., Rosenthal, E. L., Robinson, D., van der Vegt, B., Nagengast, W. B., van Dam, G. M. & Witjes, M. J. H., 16-aug.-2023, In: Nature Communications. 14, 10 blz., 4952.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand

1 Downloads (Pure)

15 Membership
7 Professional or public presentation
5 Organising and contributing to an event
4 Visiting an external institution
Meer

HER2 low mammacarcinoom - kansen en uitdagingen
Bert van der Vegt (Speaker)
14-apr.-2023
Activiteit: Academic presentation › Academic
Merck Sharp & Dohme Ltd, Merck & Company, Merck Res Labs
Bert van der Vegt (Visiting lecturer)
31-jan.-2022
Activiteit: Visiting an external institution › Professional
Ki67 in mammacarcinoom: op zoek naar de gemene deler!
Bert van der Vegt (Invited speaker)
31-mrt.-2022
Activiteit: Professional or public presentation › Professional
Abstract selection for ISCOMS 2022
Bert van der Vegt (Contributor)
2022
Activiteit: Organising and contributing to an event › Academic
Sci Comm NABON Breast Canc Audit NBCA (Externe Organisatie)
Bert van der Vegt (Member)
2022
Activiteit: Membership › Academic

Additional file 4 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
van Rooijen, J. (Contributor), Nienhuis, H. (Contributor), Van Leeuwen-Stok, E. (Contributor), de Bock, T. (Contributor), van der Vegt, B. (Contributor), Qiu, S. (Contributor), Van Deurzen, C. H. M. (Contributor), Timmer-Bosscha, H. (Contributor), de Vries, L. (Contributor), Walenkamp-Hageman, A. (Contributor) & Schröder, C. (Contributor), University of Groningen, 19-mrt.-2020
DOI: 10.6084/m9.figshare.12004491.v1, https://doi.org/10.6084%2Fm9.figshare.12004491.v1
Dataset
Additional file 7 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Schröder, C. (Contributor), van Rooijen, J. (Contributor), Walenkamp-Hageman, A. (Contributor), Van Deurzen, C. H. M. (Contributor), Qiu, S. (Contributor), de Vries, L. (Contributor), de Bock, T. (Contributor), Nienhuis, H. (Contributor), Timmer-Bosscha, H. (Contributor), van der Vegt, B. (Contributor) & Van Leeuwen-Stok, E. (Contributor), University of Groningen, 19-mrt.-2020
DOI: 10.6084/m9.figshare.12004506.v1, https://doi.org/10.6084%2Fm9.figshare.12004506.v1
Dataset
Additional file 6 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
van Rooijen, J. (Contributor), Timmer-Bosscha, H. (Contributor), Van Deurzen, C. H. M. (Contributor), Van Leeuwen-Stok, E. (Contributor), van der Vegt, B. (Contributor), de Bock, T. (Contributor), Nienhuis, H. (Contributor), Qiu, S. (Contributor), Schröder, C. (Contributor), de Vries, L. (Contributor) & Walenkamp-Hageman, A. (Contributor), University of Groningen, 19-mrt.-2020
DOI: 10.6084/m9.figshare.12004500.v1, https://doi.org/10.6084%2Fm9.figshare.12004500.v1
Dataset
Additional file 5 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Van Deurzen, C. H. M. (Contributor), Walenkamp-Hageman, A. (Contributor), Nienhuis, H. (Contributor), de Bock, T. (Contributor), van der Vegt, B. (Contributor), van Rooijen, J. (Contributor), Van Leeuwen-Stok, E. (Contributor), Schröder, C. (Contributor), Qiu, S. (Contributor), de Vries, L. (Contributor) & Timmer-Bosscha, H. (Contributor), University of Groningen, 31-mrt.-2020
DOI: 10.6084/m9.figshare.12004494.v1, https://doi.org/10.6084%2Fm9.figshare.12004494.v1
Dataset

Interview MedicalPHIT magazine on computational pathology and collaboration in pathology
Bert van der Vegt
01/05/2021
1 Mediabijdrage
Pers / media: Expert Comment › Professional
Kankercellen onder de loep
Wim Timens & Bert van der Vegt
16/04/2019
1 item van Media-aandacht
Pers / media: Activiteiten met een maatschappelijk belang › Popular
Zien welke kanker het is
Bert Vegt, van der & Willem Timens
13/04/2019
1 item van Media-aandacht
Pers / media: Activiteiten met een maatschappelijk belang › Popular

EULAR Abstract Award Basic Science
Verstappen, Gwenny (Recipient), Pringle, Sarah (Recipient), Gao, L (Recipient), Liefers, Silvia (Recipient), van der Vegt, Bert (Recipient), Patel, V (Recipient), Hu, s (Recipient), Mukherjee, S (Recipient), Vissink, Arjan (Recipient), Bootsma, Hendrika (Recipient) & Kroese, Frans (Recipient), 3-jun.-2020
Prijs: Prize › Academic
Duncan A. Gordon Award
Verstappen, Gwenny (Recipient), Kroese, Frans (Recipient), Meiners, Petra (Recipient), Corneth, Odilia (Recipient), Huitema, Minke (Recipient), Haacke, Erlin (Recipient), van der Vegt, Bert (Recipient), Arends, Suzanne (Recipient), Vissink, Arjan (Recipient), Bootsma, Hendrika (Recipient) & Abdulahad, Wayel (Recipient), 10-nov.-2019
Prijs: Prize › Academic
DASH Frontrunner project
van der Vegt, Bert (Recipient), 2018
Prijs: Other distinction › Academic

Bert van der Vegt

Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar

Duik in details

Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis

Association of Initial and Longitudinal Changes in C-reactive Protein With the Risk of Cardiovascular Disease, Cancer, and Mortality

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Digital image analysis of intraepithelial B-lymphocytes to assess lymphoepithelial lesions in salivary glands of Sjogren's syndrome patients

EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial

HER2 low mammacarcinoom - kansen en uitdagingen

Merck Sharp & Dohme Ltd, Merck & Company, Merck Res Labs

Ki67 in mammacarcinoom: op zoek naar de gemene deler!

Abstract selection for ISCOMS 2022

Sci Comm NABON Breast Canc Audit NBCA (Externe Organisatie)

Additional file 4 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Additional file 7 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Additional file 6 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Additional file 5 of High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Interview MedicalPHIT magazine on computational pathology and collaboration in pathology

Kankercellen onder de loep

Zien welke kanker het is

EULAR Abstract Award Basic Science

Duncan A. Gordon Award

DASH Frontrunner project

Bert van der Vegt

Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar

Onderzoeksoutput

Activiteiten

Datasets

Knipsels

Prijzen